Marijuana stock investors are back waiting for another rise in trading. These last few weeks have been a window of upward trading and stronger momentum. Not only did this show the possibilities of stronger trading in the future, but it also restored investors' confidence. For a long while, the cannabis sector has been on a consistent downtrend due to the politics around reform. Now that Donald Trump has voiced his concerns about federal reform for cannabis, most marijuana stocks have seen better trading.
The U.S. cannabis industry is growing rapidly. Legal sales are expected to reach $45 billion in 2025 alone. Additionally, the sector is projected to grow at a double-digit rate annually over the decade. Adult-use marijuana is now legal in nearly half of all U.S. states. Furthermore, tax revenues continue rising as more states launch legal markets. Job creation within the industry has surpassed many other sectors. As a result, investor attention has shifted toward undervalued marijuana penny stocks. These low-priced equities often carry more volatility. Therefore, using technical analysis is essential when trading them. Identifying key support and resistance zones can enhance entry and exit points. However, success also requires managing downside risk. Setting stop losses and controlling position size can help limit exposure. This week, traders are watching several names for breakouts. Industry growth, combined with policy momentum, may create short-term price action worth trading.
Some of the top marijuana stocks are still struggling to gain momentum in the market. Although this may be true for some companies, others are doing well and showing why legal cannabis makes a difference. To date, almost all of the USA and many global regions have legalized cannabis. In the US, companies were able to report strong 2025 quarterly earnings. These results range from increases in revenue and business development.
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Robert Beasley CEO | OTCQB Exchange | CA13809L1094 ISIN |
| United States Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Cansortium Inc., established in 2018 and based in Tampa, Florida, operates through its subsidiaries to provide medical cannabis in the states of Florida, Pennsylvania, and Texas. The company focuses on the production and sale of medical cannabis products, catering to patients' needs under the Fluent brand name. Alongside its proprietary products, Cansortium Inc. markets various third-party medical cannabis products, expanding its offerings to cater to a broader range of preferences and requirements within the medical cannabis community.
Under the Fluent brand name, Cansortium Inc. offers a diverse array of medical cannabis products designed to meet different consumer preferences and medical requirements:
In addition to the Fluent-branded products, Cansortium Inc. also provides a selection of third-party branded medical cannabis products, ensuring patients have access to a wide range of therapeutic options.